Johnson & Johnson
JNJNYSEPharmaceuticals
$253.28
Down−$0.63 (−0.25%)today
Market closed · refreshes every 30sLast trade Oct 15, 4:00 PM EDT
Key stats
- Open
- $257.11
- Previous close
- $253.91
- Day range
- $252.62 – $262.45
- 52-week range
- $184.66 – $281.07
- Market cap
- $610.38B
- P/E ratio
- 38.77
- Dividend yield
- 3.12%
- Beta
- 0.20
News about JNJ
- Yahoo3 Companies Raising Guidance This Earnings Season
Raised guidance is always a welcome development for investors, reflecting improving business trends and management confidence in the outlook.
- YahooIs Medtronic Stock A Buy Now That Sales Growth Has Picked Up?
Investors considering Medtronic (MDT) stock face an immediate concern: the shares returned 1.9% over the past year, trailing the 17.3% gain for the S&P 500. Yet Medtronic raised its outlook for the year in September, following higher fiscal first-quarter profit and sales. The company is also splitting off MiniMed Group, meaning the business you buy today is changing. So how much faster is Medtronic actually growing.
- YahooHow Has Merck's Story Changed?
Investors are pricing Merck (MRK) stock at 5.5 times sales, compared with 3.1 for the S&P 500. Shareholders paying that premium need to understand exactly what they hold, and the drugmaker's priorities have changed. During the fiscal Q4 2024 call in February 2025, executives noted that conditions for the GARDASIL vaccine in China remained challenging. By the August 4, 2026 call, management emphasized something else. So what does management talk up now.
- YahooIs Boston Scientific Stock Riskier Than It Was A Year Ago?
Your position
Sign in to track your JNJ shares and return.
Add to portfolioAbout
- Exchange
- NYSE
- Industry
- Pharmaceuticals
- Listed
- 1944-09-25